Breadcrumb Home Machine Learning in Drug Discovery Symposium Agenda Machine Learning in Drug Discovery Symposium Getting here Archive 2025 Overview Agenda Speakers Organizers Advisory Committee Organizing Committee Workshop 2024 Overview Speakers Organizers Advisory Comittee Organizing Committee Agenda Workshop 2023 Overview Agenda Organizers Advisory Comittee Organizing Committee 2022 Organizers Advisory Committee Organizing Committee Day 1, November 6, 2025 12:00 - 5:00 pm Workshop Day 2, November 7, 2025 8:00 - 6:00 pm Symposium 8:00 - 9:00 am Registration and Breakfast Opening Session 9:00 - 9:10 am Welcome Sumaiya Iqbal Ó³»´«Ã½ 9:10 - 9:25 am Opening Remarks and Keynote Introduction Stacey Gabriel Ó³»´«Ã½ Keynote 9:30 - 10:30 am Keynote From Models to Medicines: Delivering on the Promise of AI-Driven Drug Discovery Thomas Miller Iambic Therapeutics Morning Session Chair: Sumaiya Iqbal 10:30 - 11:10 am Foundation models in biomedicine: from modeling the tissue to modeling all of biology. Bioptimus 11:10 - 11:30 am Break and Poster Viewing 11:30 - 12:10 pm Integrating Physics-Based Simulations and AI to Drug Challenging Targets from the TNF Superfamily and Beyond Psivant Therapeutics 12:10 - 12:30 pm Lightning Talks F.A.D.E. (Fully Agentic Drug Engine): A Conversational AI Platform for Drug Discovery Xue Zong Georgia Institute of Technology PostaNet: Ai-based Framework for Protein Stability Prediction with Experimental Validation Tianjian Liang University of Pittsburgh Genomic Language Models Decipher the Regulatory Code of Splicing for Drug Sensitivity Xueyang He University of Rochester ATLAS Breaks Data Scaling Barriers for MachineLearning via High-Throughput Synthesis and Screening Imran Haque Kimia Therapeutics 12:30 - 2:00 pm Lunch and Poster Viewing Afternoon Session Chair: Wengong Jin 2:00 - 2:40 pm Charting the dark chemical universe with deep learning in low-data scenarios Eindhoven University of Technology 2:40 - 3:00 pm Empowering Biomedical Discovery with "AI Scientists" Harvard Medical School Ó³»´«Ã½ 3:00 - 3:10 pm Awards and Certificates. Moderator: Sumaiya Iqbal AFFIL 3:10 - 3:30 pm Break and Poster Viewing 3:30 - 3:50 pm Foundation Models for Early Drug Discovery Recursion 3:50 - 4:10 pm Modeling and targeting cell states in cancer Microsoft Research 4:10 - 4:30 pm Designing inhibitors of fibroblast activation protein (FAP) using REINVENT AstraZeneca 4:30 - 4:45 pm Closing Remarks and Acknowledgement AFFIL 4:45 - 6:00 pm Reception and poster session Latest news News 04.16.2026 Clinical trial of a prion disease drug candidate begins enrolling participants News 04.15.2026 Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution News 04.14.2026 Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics News 04.14.2026 Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder All news
News 04.15.2026 Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution
News 04.14.2026 Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics
News 04.14.2026 Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder